APO Research
Talk to an analyst

APO RESEARCH · REPORT

Acne Medicine

The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.

Selected research

Market Analysis & Forecast

Global Acne Medicine Market Analysis and Forecast 2026-2032

28 December 2025195 pages

Choose your research edition.

Industry ResearchAcne Medicine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Acne Medicine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Acne Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Acne Medicine Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Acne Medicine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The most common topical prescription medications for acne are retinoids and retinoid-like drugs, antibiotics, azelaic acid and salicylic acid, dapsone. The most common oral medications for acne are antibiotics, combined oral contraceptives, anti-androgen agents, and isotretinoin.

By type，in 2020, Prescription Medicine accounted for a share of 78% in the global Acne Medicine market. In Acne Medicine market, the Topical holds an important share in terms of Application about74.17%.

Report Includes

Read the full market overview

This report presents an overview of global market for Acne Medicine, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Acne Medicine, also provides the revenue of main regions and countries. Of the upcoming market potential for Acne Medicine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Acne Medicine revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Acne Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Acne Medicine revenue, projected growth trends, production technology, application and end-user industry.

Acne Medicine Segment by Company

Galderma

Bausch Health

Teva

GlaxoSmithKline

Mylan

Almirall

Sun Pharma

Mayne Pharma

Lion

HUAPONT

Sine Pharma

Acne Medicine Segment by Type

OTC

Prescription Medicine

Acne Medicine Segment by Application

Topical

Oral

Acne Medicine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Acne Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Acne Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Acne Medicine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Acne Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Acne Medicine company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Acne Medicine revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Acne Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. OTC Major Player Table 3. Prescription Medicine Major Player Table 4. Global Acne Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Topical Major Player Table 6. Oral Major Player Table 7. Acne Medicine Industry Trends Table 8. Acne Medicine Industry Drivers Table 9. Acne Medicine Industry Opportunities and Challenges Table 10. Acne Medicine Industry Restraints Table 11. Global Acne Medicine Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Acne Medicine Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Acne Medicine Market Share by Region (2021-2026) Table 14. Global Acne Medicine Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Acne Medicine Market Share by Region (2027-2032) Table 16. Global Acne Medicine Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Acne Medicine Revenue Market Share by Players (2021-2026) Table 18. Global Acne Medicine Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Acne Medicine Key Players Headquarters & Area Served Table 20. Global Acne Medicine Players, Product Type & Application Table 21. Global Acne Medicine Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Acne Medicine by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Acne Medicine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Acne Medicine Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Acne Medicine Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Acne Medicine Revenue Market Share by Type (2021-2026) Table 28. Global Acne Medicine Revenue Market Share by Type (2027-2032) Table 29. Global Acne Medicine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Acne Medicine Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Acne Medicine Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Acne Medicine Revenue Market Share by Application (2021-2026) Table 33. Global Acne Medicine Revenue Market Share by Application (2027-2032) Table 34. Galderma Company Information Table 35. Galderma Business Overview Table 36. Galderma Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Galderma Acne Medicine Product Portfolio Table 38. Galderma Recent Development Table 39. Bausch Health Company Information Table 40. Bausch Health Business Overview Table 41. Bausch Health Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Bausch Health Acne Medicine Product Portfolio Table 43. Bausch Health Recent Development Table 44. Teva Company Information Table 45. Teva Business Overview Table 46. Teva Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Teva Acne Medicine Product Portfolio Table 48. Teva Recent Development Table 49. GlaxoSmithKline Company Information Table 50. GlaxoSmithKline Business Overview Table 51. GlaxoSmithKline Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. GlaxoSmithKline Acne Medicine Product Portfolio Table 53. GlaxoSmithKline Recent Development Table 54. Mylan Company Information Table 55. Mylan Business Overview Table 56. Mylan Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. Mylan Acne Medicine Product Portfolio Table 58. Mylan Recent Development Table 59. Almirall Company Information Table 60. Almirall Business Overview Table 61. Almirall Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. Almirall Acne Medicine Product Portfolio Table 63. Almirall Recent Development Table 64. Sun Pharma Company Information Table 65. Sun Pharma Business Overview Table 66. Sun Pharma Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Sun Pharma Acne Medicine Product Portfolio Table 68. Sun Pharma Recent Development Table 69. Mayne Pharma Company Information Table 70. Mayne Pharma Business Overview Table 71. Mayne Pharma Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Mayne Pharma Acne Medicine Product Portfolio Table 73. Mayne Pharma Recent Development Table 74. Lion Company Information Table 75. Lion Business Overview Table 76. Lion Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Lion Acne Medicine Product Portfolio Table 78. Lion Recent Development Table 79. HUAPONT Company Information Table 80. HUAPONT Business Overview Table 81. HUAPONT Acne Medicine Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. HUAPONT Acne Medicine Product Portfolio Table 83. HUAPONT Recent Development Table 84. Sine Pharma Company Information Table 85. Sine Pharma Business Overview Table 86. Sine Pharma Acne Medicine Sales (units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Sine Pharma Acne Medicine Product Portfolio Table 88. Sine Pharma Recent Development Table 89. North America Acne Medicine Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Acne Medicine Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Acne Medicine Revenue by Application (2021-2026) & (US$ Million) Table 92. North America Acne Medicine Revenue by Application (2027-2032) & (US$ Million) Table 93. North America Acne Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 94. North America Acne Medicine Revenue by Country (2021-2026) & (US$ Million) Table 95. North America Acne Medicine Revenue by Country (US$ Million) & (2027-2032) Table 96. Europe Acne Medicine Revenue by Type (2021-2026) & (US$ Million) Table 97. Europe Acne Medicine Revenue by Type (2027-2032) & (US$ Million) Table 98. Europe Acne Medicine Revenue by Application (2021-2026) & (US$ Million) Table 99. Europe Acne Medicine Revenue by Application (2027-2032) & (US$ Million) Table 100. Europe Acne Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 101. Europe Acne Medicine Revenue by Country (2021-2026) & (US$ Million) Table 102. Europe Acne Medicine Revenue by Country (US$ Million) & (2027-2032) Table 103. China Acne Medicine Revenue by Type (2021-2026) & (US$ Million) Table 104. China Acne Medicine Revenue by Type (2027-2032) & (US$ Million) Table 105. China Acne Medicine Revenue by Application (2021-2026) & (US$ Million) Table 106. China Acne Medicine Revenue by Application (2027-2032) & (US$ Million) Table 107. Asia Acne Medicine Revenue by Type (2021-2026) & (US$ Million) Table 108. Asia Acne Medicine Revenue by Type (2027-2032) & (US$ Million) Table 109. Asia Acne Medicine Revenue by Application (2021-2026) & (US$ Million) Table 110. Asia Acne Medicine Revenue by Application (2027-2032) & (US$ Million) Table 111. Asia Acne Medicine Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Asia Acne Medicine Revenue by Region (US$ Million) & (2021-2026) Table 113. Asia Acne Medicine Revenue by Region (US$ Million) & (2027-2032) Table 114. SAMEA Acne Medicine Revenue by Type (2021-2026) & (US$ Million) Table 115. SAMEA Acne Medicine Revenue by Type (2027-2032) & (US$ Million) Table 116. SAMEA Acne Medicine Revenue by Application (2021-2026) & (US$ Million) Table 117. SAMEA Acne Medicine Revenue by Application (2027-2032) & (US$ Million) Table 118. SAMEA Acne Medicine Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. SAMEA Acne Medicine Revenue by Country (2021-2026) & (US$ Million) Table 120. SAMEA Acne Medicine Revenue by Country (US$ Million) & (2027-2032) Table 121. Research Programs/Design for This Report Table 122. Authors List of This Report Table 123. Secondary Sources Table 124. Primary Sources List of Figures Figure 1. Acne Medicine Image Figure 2. Global Acne Medicine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Acne Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 4. OTC Image Figure 5. Prescription Medicine Image Figure 6. Global Acne Medicine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Acne Medicine Market Size Share 2021 VS 2025 VS 2032 Figure 8. Topical Image Figure 9. Oral Image Figure 10. Global Acne Medicine Market Size (US$ Million) & (2021-2032) Figure 11. Global Acne Medicine Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Acne Medicine Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Acne Medicine Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Acne Medicine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Acne Medicine Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Acne Medicine Revenue Market Share by Type (2021-2032) Figure 18. Global Acne Medicine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Acne Medicine Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Acne Medicine Revenue Market Share by Application (2021-2032) Figure 21. North America Acne Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Acne Medicine Revenue Share by Type (2021-2032) Figure 23. North America Acne Medicine Revenue Share by Application (2021-2032) Figure 24. North America Acne Medicine Revenue Share by Country (2021-2032) Figure 25. United States Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Acne Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Acne Medicine Revenue Share by Type (2021-2032) Figure 30. Europe Acne Medicine Revenue Share by Application (2021-2032) Figure 31. Europe Acne Medicine Revenue Share by Country (2021-2032) Figure 32. Germany Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Acne Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Acne Medicine Revenue Share by Type (2021-2032) Figure 42. China Acne Medicine Revenue Share by Application (2021-2032) Figure 43. Asia Acne Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Acne Medicine Revenue Share by Type (2021-2032) Figure 45. Asia Acne Medicine Revenue Share by Application (2021-2032) Figure 46. Asia Acne Medicine Revenue Share by Region (2021-2032) Figure 47. Japan Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Acne Medicine Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Acne Medicine Revenue Share by Type (2021-2032) Figure 55. SAMEA Acne Medicine Revenue Share by Application (2021-2032) Figure 56. SAMEA Acne Medicine Revenue Share by Country (2021-2032) Figure 57. Brazil Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Acne Medicine Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Prescription Medicine
Applications
  • Topical
  • Oral
Companies covered
  • Galderma
  • Bausch Health
  • Teva
  • GlaxoSmithKline
  • Mylan
  • Almirall
  • Sun Pharma
  • Mayne Pharma
  • Lion
  • HUAPONT
  • Sine Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Acne Medicine Market by Type
  3. 1.2.1 Global Acne Medicine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 OTC
  5. 1.2.3 Prescription Medicine
  6. 1.3 Acne Medicine Market by Application
  7. 1.3.1 Global Acne Medicine Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Topical
  9. 1.3.3 Oral
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Acne Medicine Market Dynamics
  1. 2.1 Acne Medicine Industry Trends
  2. 2.2 Acne Medicine Industry Drivers
  3. 2.3 Acne Medicine Industry Opportunities and Challenges
  4. 2.4 Acne Medicine Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Acne Medicine Market Perspective (2021-2032)
  2. 3.2 Global Acne Medicine Growth Trends by Region
  3. 3.2.1 Global Acne Medicine Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Acne Medicine Market Size by Region (2021-2026)
  5. 3.2.3 Global Acne Medicine Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Acne Medicine Revenue by Players
  2. 4.1.1 Global Acne Medicine Revenue by Players (2021-2026)
  3. 4.1.2 Global Acne Medicine Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Acne Medicine Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Acne Medicine Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Acne Medicine Key Players Headquarters & Area Served
  7. 4.4 Global Acne Medicine Players, Product Type & Application
  8. 4.5 Global Acne Medicine Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Acne Medicine Market CR5 and HHI
  11. 4.6.3 2025 Acne Medicine Tier 1, Tier 2, and Tier 3
5 Acne Medicine Market Size by Type
  1. 5.1 Global Acne Medicine Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Acne Medicine Revenue by Type (2021-2032)
  3. 5.3 Global Acne Medicine Revenue Market Share by Type (2021-2032)
6 Acne Medicine Market Size by Application
  1. 6.1 Global Acne Medicine Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Acne Medicine Revenue by Application (2021-2032)
  3. 6.3 Global Acne Medicine Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Galderma
  2. 7.1.1 Galderma Company Information
  3. 7.1.2 Galderma Business Overview
  4. 7.1.3 Galderma Acne Medicine Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Galderma Acne Medicine Product Portfolio
  6. 7.1.5 Galderma Recent Developments
  7. 7.2 Bausch Health
  8. 7.2.1 Bausch Health Company Information
  9. 7.2.2 Bausch Health Business Overview
  10. 7.2.3 Bausch Health Acne Medicine Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Bausch Health Acne Medicine Product Portfolio
  12. 7.2.5 Bausch Health Recent Developments
  13. 7.3 Teva
  14. 7.3.1 Teva Company Information
  15. 7.3.2 Teva Business Overview
  16. 7.3.3 Teva Acne Medicine Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Teva Acne Medicine Product Portfolio
  18. 7.3.5 Teva Recent Developments
  19. 7.4 GlaxoSmithKline
  20. 7.4.1 GlaxoSmithKline Company Information
  21. 7.4.2 GlaxoSmithKline Business Overview
  22. 7.4.3 GlaxoSmithKline Acne Medicine Revenue and Gross Margin (2021-2026)
  23. 7.4.4 GlaxoSmithKline Acne Medicine Product Portfolio
  24. 7.4.5 GlaxoSmithKline Recent Developments
  25. 7.5 Mylan
  26. 7.5.1 Mylan Company Information
  27. 7.5.2 Mylan Business Overview
  28. 7.5.3 Mylan Acne Medicine Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Mylan Acne Medicine Product Portfolio
  30. 7.5.5 Mylan Recent Developments
  31. 7.6 Almirall
  32. 7.6.1 Almirall Company Information
  33. 7.6.2 Almirall Business Overview
  34. 7.6.3 Almirall Acne Medicine Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Almirall Acne Medicine Product Portfolio
  36. 7.6.5 Almirall Recent Developments
  37. 7.7 Sun Pharma
  38. 7.7.1 Sun Pharma Company Information
  39. 7.7.2 Sun Pharma Business Overview
  40. 7.7.3 Sun Pharma Acne Medicine Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Sun Pharma Acne Medicine Product Portfolio
  42. 7.7.5 Sun Pharma Recent Developments
  43. 7.8 Mayne Pharma
  44. 7.8.1 Mayne Pharma Company Information
  45. 7.8.2 Mayne Pharma Business Overview
  46. 7.8.3 Mayne Pharma Acne Medicine Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Mayne Pharma Acne Medicine Product Portfolio
  48. 7.8.5 Mayne Pharma Recent Developments
  49. 7.9 Lion
  50. 7.9.1 Lion Company Information
  51. 7.9.2 Lion Business Overview
  52. 7.9.3 Lion Acne Medicine Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Lion Acne Medicine Product Portfolio
  54. 7.9.5 Lion Recent Developments
  55. 7.10 HUAPONT
  56. 7.10.1 HUAPONT Company Information
  57. 7.10.2 HUAPONT Business Overview
  58. 7.10.3 HUAPONT Acne Medicine Revenue and Gross Margin (2021-2026)
  59. 7.10.4 HUAPONT Acne Medicine Product Portfolio
  60. 7.10.5 HUAPONT Recent Developments
  61. 7.11 Sine Pharma
  62. 7.11.1 Sine Pharma Company Information
  63. 7.11.2 Sine Pharma Business Overview
  64. 7.11.3 Sine Pharma Acne Medicine Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Sine Pharma Acne Medicine Product Portfolio
  66. 7.11.5 Sine Pharma Recent Developments
8 North America
  1. 8.1 North America Acne Medicine Revenue (2021-2032)
  2. 8.2 North America Acne Medicine Revenue by Type (2021-2032)
  3. 8.2.1 North America Acne Medicine Revenue by Type (2021-2026)
  4. 8.2.2 North America Acne Medicine Revenue by Type (2027-2032)
  5. 8.3 North America Acne Medicine Revenue Share by Type (2021-2032)
  6. 8.4 North America Acne Medicine Revenue by Application (2021-2032)
  7. 8.4.1 North America Acne Medicine Revenue by Application (2021-2026)
  8. 8.4.2 North America Acne Medicine Revenue by Application (2027-2032)
  9. 8.5 North America Acne Medicine Revenue Share by Application (2021-2032)
  10. 8.6 North America Acne Medicine Revenue by Country
  11. 8.6.1 North America Acne Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Acne Medicine Revenue by Country (2021-2026)
  13. 8.6.3 North America Acne Medicine Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Acne Medicine Revenue (2021-2032)
  2. 9.2 Europe Acne Medicine Revenue by Type (2021-2032)
  3. 9.2.1 Europe Acne Medicine Revenue by Type (2021-2026)
  4. 9.2.2 Europe Acne Medicine Revenue by Type (2027-2032)
  5. 9.3 Europe Acne Medicine Revenue Share by Type (2021-2032)
  6. 9.4 Europe Acne Medicine Revenue by Application (2021-2032)
  7. 9.4.1 Europe Acne Medicine Revenue by Application (2021-2026)
  8. 9.4.2 Europe Acne Medicine Revenue by Application (2027-2032)
  9. 9.5 Europe Acne Medicine Revenue Share by Application (2021-2032)
  10. 9.6 Europe Acne Medicine Revenue by Country
  11. 9.6.1 Europe Acne Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Acne Medicine Revenue by Country (2021-2026)
  13. 9.6.3 Europe Acne Medicine Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Acne Medicine Revenue (2021-2032)
  2. 10.2 China Acne Medicine Revenue by Type (2021-2032)
  3. 10.2.1 China Acne Medicine Revenue by Type (2021-2026)
  4. 10.2.2 China Acne Medicine Revenue by Type (2027-2032)
  5. 10.3 China Acne Medicine Revenue Share by Type (2021-2032)
  6. 10.4 China Acne Medicine Revenue by Application (2021-2032)
  7. 10.4.1 China Acne Medicine Revenue by Application (2021-2026)
  8. 10.4.2 China Acne Medicine Revenue by Application (2027-2032)
  9. 10.5 China Acne Medicine Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Acne Medicine Revenue (2021-2032)
  2. 11.2 Asia Acne Medicine Revenue by Type (2021-2032)
  3. 11.2.1 Asia Acne Medicine Revenue by Type (2021-2026)
  4. 11.2.2 Asia Acne Medicine Revenue by Type (2027-2032)
  5. 11.3 Asia Acne Medicine Revenue Share by Type (2021-2032)
  6. 11.4 Asia Acne Medicine Revenue by Application (2021-2032)
  7. 11.4.1 Asia Acne Medicine Revenue by Application (2021-2026)
  8. 11.4.2 Asia Acne Medicine Revenue by Application (2027-2032)
  9. 11.5 Asia Acne Medicine Revenue Share by Application (2021-2032)
  10. 11.6 Asia Acne Medicine Revenue by Country
  11. 11.6.1 Asia Acne Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Acne Medicine Revenue by Country (2021-2026)
  13. 11.6.3 Asia Acne Medicine Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Acne Medicine Revenue (2021-2032)
  2. 12.2 SAMEA Acne Medicine Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Acne Medicine Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Acne Medicine Revenue by Type (2027-2032)
  5. 12.3 SAMEA Acne Medicine Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Acne Medicine Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Acne Medicine Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Acne Medicine Revenue by Application (2027-2032)
  9. 12.5 SAMEA Acne Medicine Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Acne Medicine Revenue by Country
  11. 12.6.1 SAMEA Acne Medicine Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Acne Medicine Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Acne Medicine Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst